Xiaoli Zuo
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Sperm and Testicular Function
Papers in
-
- Extracellular vesicles in disease 3
- Kruppel-like factors research 1
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Co-authors
- Bowen Rong (1 shared paper)Ming‐Han Tong (1 shared paper)Fei Lan (1 shared paper)Li Li (1 shared paper)Ruitu Lv (1 shared paper)Bingqing Xia (4 shared papers)Zhaobing Gao (5 shared papers)Stephen J. Rossiter (1 shared paper)
- Journals
- Frontiers in Cell and Developmental Biology (1 paper)Journal of Biological Chemistry (1 paper)Molecular Biology and Evolution (1 paper)Cell Discovery (1 paper)Journal of Medical Virology (1 paper)
- Partner nations
- ChinaUnited KingdomEthiopia
In The Last Decade
Xiaoli Zuo
11 papers receiving 172 citations
Peers
Comparison fields: 5 of 58
- Infectious Diseases 43
- Reproductive Medicine 17
- Developmental Biology 4
- Molecular Biology 108
- Genetics 37
Countries citing papers authored by Xiaoli Zuo
This map shows the geographic impact of Xiaoli Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Zuo more than expected).
Fields of papers citing papers by Xiaoli Zuo
This network shows the impact of papers produced by Xiaoli Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Zuo. The network helps show where Xiaoli Zuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Zuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 51 | |
| 2 | 2023 | 42 | |
| 3 | 2008 | 39 | |
| 4 | 2022 | 17 | |
| 5 | 2016 | 11 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2025 | 1 | |
| 11 | 2024 | 1 |
About Xiaoli Zuo
Xiaoli Zuo is a scholar working on Molecular Biology, Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology and Nephrology, having authored 11 papers that have together received 175 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Extracellular vesicles in disease (3 papers), Pregnancy and Medication Impact (2 papers), COVID-19 Clinical Research Studies (2 papers), interferon and immune responses (1 paper), Kruppel-like factors research (1 paper), Trace Elements in Health (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Infectious Diseases (43 citations), Reproductive Medicine (17 citations), Developmental Biology (4 citations), Molecular Biology (108 citations) and Genetics (37 citations). Xiaoli Zuo has collaborated with scholars based in China, United Kingdom and Ethiopia. Frequent co-authors include Bowen Rong, Ming‐Han Tong, Fei Lan, Li Li, Ruitu Lv, Bingqing Xia, Zhaobing Gao, Stephen J. Rossiter, Jia Li and Xiaoyan Pan. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Journal of Biological Chemistry, Molecular Biology and Evolution, Cell Discovery and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.